Global Spinal Devices and Biologics Market Insights and Forecast to 2026

Publisher Name :
Date: 20-Jul-2020
No. of pages: 112
Inquire Before Buying

Spinal Devices and Biologics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Spinal Devices and Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Spinal Devices and Biologics market is segmented into

- Spinal Fusion & Fixation

- Motion Preservation

- Non-Fusion Technologies

- Fracture Treatment

- Other

Segment by Application, the Spinal Devices and Biologics market is segmented into

- Hospitals

- Ambulatory Surgical Centers

- Clinics

- Other

Regional and Country-level Analysis

The Spinal Devices and Biologics market is analysed and market size information is provided by regions (countries).

The key regions covered in the Spinal Devices and Biologics market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.

Competitive Landscape and Spinal Devices and Biologics Market Share Analysis

Spinal Devices and Biologics market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Spinal Devices and Biologics by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Spinal Devices and Biologics business, the date to enter into the Spinal Devices and Biologics market, Spinal Devices and Biologics product introduction, recent developments, etc.

The major vendors covered:

- Nuvasive

- Orthofix International

- Exactech

- Wright Medical Group

- Johnson & Johnson

- Zimmer Biomet

- Globus Medical

- K2M

- Medtronic

- Alphatec Holdings

- RTI Surgical

Global Spinal Devices and Biologics Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Spinal Devices and Biologics Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Spinal Devices and Biologics Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Spinal Devices and Biologics Market Size Growth Rate by Type
1.4.2 Spinal Fusion & Fixation
1.4.3 Motion Preservation
1.4.4 Non-Fusion Technologies
1.4.5 Fracture Treatment
1.4.6 Other
1.5 Market by Application
1.5.1 Global Spinal Devices and Biologics Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Clinics
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Spinal Devices and Biologics Market Size, Estimates and Forecasts
2.1.1 Global Spinal Devices and Biologics Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Spinal Devices and Biologics Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Spinal Devices and Biologics Production Estimates and Forecasts 2015-2026
2.2 Global Spinal Devices and Biologics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Spinal Devices and Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Spinal Devices and Biologics Manufacturers Geographical Distribution
2.4 Key Trends for Spinal Devices and Biologics Markets & Products
2.5 Primary Interviews with Key Spinal Devices and Biologics Players (Opinion Leaders)
3 Market Size by Manufacturers
3.1 Global Top Spinal Devices and Biologics Manufacturers by Production Capacity
3.1.1 Global Top Spinal Devices and Biologics Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Spinal Devices and Biologics Manufacturers by Production (2015-2020)
3.1.3 Global Top Spinal Devices and Biologics Manufacturers Market Share by Production
3.2 Global Top Spinal Devices and Biologics Manufacturers by Revenue
3.2.1 Global Top Spinal Devices and Biologics Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Spinal Devices and Biologics Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Spinal Devices and Biologics Revenue in 2019
3.3 Global Spinal Devices and Biologics Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Spinal Devices and Biologics Production by Regions
4.1 Global Spinal Devices and Biologics Historic Market Facts & Figures by Regions
4.1.1 Global Top Spinal Devices and Biologics Regions by Production (2015-2020)
4.1.2 Global Top Spinal Devices and Biologics Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Spinal Devices and Biologics Production (2015-2020)
4.2.2 North America Spinal Devices and Biologics Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Spinal Devices and Biologics Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Spinal Devices and Biologics Production (2015-2020)
4.3.2 Europe Spinal Devices and Biologics Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Spinal Devices and Biologics Import & Export (2015-2020)
4.4 China
4.4.1 China Spinal Devices and Biologics Production (2015-2020)
4.4.2 China Spinal Devices and Biologics Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Spinal Devices and Biologics Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Spinal Devices and Biologics Production (2015-2020)
4.5.2 Japan Spinal Devices and Biologics Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Spinal Devices and Biologics Import & Export (2015-2020)
5 Spinal Devices and Biologics Consumption by Region
5.1 Global Top Spinal Devices and Biologics Regions by Consumption
5.1.1 Global Top Spinal Devices and Biologics Regions by Consumption (2015-2020)
5.1.2 Global Top Spinal Devices and Biologics Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Spinal Devices and Biologics Consumption by Application
5.2.2 North America Spinal Devices and Biologics Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Spinal Devices and Biologics Consumption by Application
5.3.2 Europe Spinal Devices and Biologics Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Spinal Devices and Biologics Consumption by Application
5.4.2 Asia Pacific Spinal Devices and Biologics Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Spinal Devices and Biologics Consumption by Application
5.5.2 Central & South America Spinal Devices and Biologics Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Spinal Devices and Biologics Consumption by Application
5.6.2 Middle East and Africa Spinal Devices and Biologics Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 Market Size by Type (2015-2026)
6.1 Global Spinal Devices and Biologics Market Size by Type (2015-2020)
6.1.1 Global Spinal Devices and Biologics Production by Type (2015-2020)
6.1.2 Global Spinal Devices and Biologics Revenue by Type (2015-2020)
6.1.3 Spinal Devices and Biologics Price by Type (2015-2020)
6.2 Global Spinal Devices and Biologics Market Forecast by Type (2021-2026)
6.2.1 Global Spinal Devices and Biologics Production Forecast by Type (2021-2026)
6.2.2 Global Spinal Devices and Biologics Revenue Forecast by Type (2021-2026)
6.2.3 Global Spinal Devices and Biologics Price Forecast by Type (2021-2026)
6.3 Global Spinal Devices and Biologics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
7.2.1 Global Spinal Devices and Biologics Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Spinal Devices and Biologics Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
8.1 Nuvasive
8.1.1 Nuvasive Corporation Information
8.1.2 Nuvasive Overview
8.1.3 Nuvasive Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Nuvasive Product Description
8.1.5 Nuvasive Related Developments
8.2 Orthofix International
8.2.1 Orthofix International Corporation Information
8.2.2 Orthofix International Overview
8.2.3 Orthofix International Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Orthofix International Product Description
8.2.5 Orthofix International Related Developments
8.3 Exactech
8.3.1 Exactech Corporation Information
8.3.2 Exactech Overview
8.3.3 Exactech Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Exactech Product Description
8.3.5 Exactech Related Developments
8.4 Wright Medical Group
8.4.1 Wright Medical Group Corporation Information
8.4.2 Wright Medical Group Overview
8.4.3 Wright Medical Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Wright Medical Group Product Description
8.4.5 Wright Medical Group Related Developments
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Corporation Information
8.5.2 Johnson & Johnson Overview
8.5.3 Johnson & Johnson Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Johnson & Johnson Product Description
8.5.5 Johnson & Johnson Related Developments
8.6 Zimmer Biomet
8.6.1 Zimmer Biomet Corporation Information
8.6.2 Zimmer Biomet Overview
8.6.3 Zimmer Biomet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Zimmer Biomet Product Description
8.6.5 Zimmer Biomet Related Developments
8.7 Globus Medical
8.7.1 Globus Medical Corporation Information
8.7.2 Globus Medical Overview
8.7.3 Globus Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Globus Medical Product Description
8.7.5 Globus Medical Related Developments
8.8 K2M
8.8.1 K2M Corporation Information
8.8.2 K2M Overview
8.8.3 K2M Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 K2M Product Description
8.8.5 K2M Related Developments
8.9 Medtronic
8.9.1 Medtronic Corporation Information
8.9.2 Medtronic Overview
8.9.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Medtronic Product Description
8.9.5 Medtronic Related Developments
8.10 Alphatec Holdings
8.10.1 Alphatec Holdings Corporation Information
8.10.2 Alphatec Holdings Overview
8.10.3 Alphatec Holdings Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Alphatec Holdings Product Description
8.10.5 Alphatec Holdings Related Developments
8.11 RTI Surgical
8.11.1 RTI Surgical Corporation Information
8.11.2 RTI Surgical Overview
8.11.3 RTI Surgical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 RTI Surgical Product Description
8.11.5 RTI Surgical Related Developments
9 Spinal Devices and Biologics Production Forecast by Regions
9.1 Global Top Spinal Devices and Biologics Regions Forecast by Revenue (2021-2026)
9.2 Global Top Spinal Devices and Biologics Regions Forecast by Production (2021-2026)
9.3 Key Spinal Devices and Biologics Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 Spinal Devices and Biologics Consumption Forecast by Region
10.1 Global Spinal Devices and Biologics Consumption Forecast by Region (2021-2026)
10.2 North America Spinal Devices and Biologics Consumption Forecast by Region (2021-2026)
10.3 Europe Spinal Devices and Biologics Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Spinal Devices and Biologics Consumption Forecast by Region (2021-2026)
10.5 Latin America Spinal Devices and Biologics Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Spinal Devices and Biologics Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Spinal Devices and Biologics Sales Channels
11.2.2 Spinal Devices and Biologics Distributors
11.3 Spinal Devices and Biologics Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Spinal Devices and Biologics Industry
12.2 Market Trends
12.3 Market Opportunities and Drivers
12.4 Market Challenges
12.5 Spinal Devices and Biologics Market Risks/Restraints
12.6 Porter's Five Forces Analysis
13 Key Finding in The Global Spinal Devices and Biologics Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Spinal Devices and Biologics Key Market Segments in This Study
Table 2. Ranking of Global Top Spinal Devices and Biologics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Spinal Devices and Biologics Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Spinal Fusion & Fixation
Table 5. Major Manufacturers of Motion Preservation
Table 6. Major Manufacturers of Non-Fusion Technologies
Table 7. Major Manufacturers of Fracture Treatment
Table 8. Major Manufacturers of Other
Table 9. Global Spinal Devices and Biologics Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Spinal Devices and Biologics Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 11. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 12. Global Spinal Devices and Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Devices and Biologics as of 2019)
Table 13. Spinal Devices and Biologics Manufacturing Base Distribution and Headquarters
Table 14. Manufacturers Spinal Devices and Biologics Product Offered
Table 15. Date of Manufacturers Enter into Spinal Devices and Biologics Market
Table 16. Key Trends for Spinal Devices and Biologics Markets & Products
Table 17. Main Points Interviewed from Key Spinal Devices and Biologics Players
Table 18. Global Spinal Devices and Biologics Production Capacity by Manufacturers (2015-2020) (K Units)
Table 19. Global Spinal Devices and Biologics Production Share by Manufacturers (2015-2020)
Table 20. Spinal Devices and Biologics Revenue by Manufacturers (2015-2020) (Million US$)
Table 21. Spinal Devices and Biologics Revenue Share by Manufacturers (2015-2020)
Table 22. Spinal Devices and Biologics Price by Manufacturers 2015-2020 (USD/Unit)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Spinal Devices and Biologics Production by Regions (2015-2020) (K Units)
Table 25. Global Spinal Devices and Biologics Production Market Share by Regions (2015-2020)
Table 26. Global Spinal Devices and Biologics Revenue by Regions (2015-2020) (US$ Million)
Table 27. Global Spinal Devices and Biologics Revenue Market Share by Regions (2015-2020)
Table 28. Key Spinal Devices and Biologics Players in North America
Table 29. Import & Export of Spinal Devices and Biologics in North America (K Units)
Table 30. Key Spinal Devices and Biologics Players in Europe
Table 31. Import & Export of Spinal Devices and Biologics in Europe (K Units)
Table 32. Key Spinal Devices and Biologics Players in China
Table 33. Import & Export of Spinal Devices and Biologics in China (K Units)
Table 34. Key Spinal Devices and Biologics Players in Japan
Table 35. Import & Export of Spinal Devices and Biologics in Japan (K Units)
Table 36. Global Spinal Devices and Biologics Consumption by Regions (2015-2020) (K Units)
Table 37. Global Spinal Devices and Biologics Consumption Market Share by Regions (2015-2020)
Table 38. North America Spinal Devices and Biologics Consumption by Application (2015-2020) (K Units)
Table 39. North America Spinal Devices and Biologics Consumption by Countries (2015-2020) (K Units)
Table 40. Europe Spinal Devices and Biologics Consumption by Application (2015-2020) (K Units)
Table 41. Europe Spinal Devices and Biologics Consumption by Countries (2015-2020) (K Units)
Table 42. Asia Pacific Spinal Devices and Biologics Consumption by Application (2015-2020) (K Units)
Table 43. Asia Pacific Spinal Devices and Biologics Consumption Market Share by Application (2015-2020) (K Units)
Table 44. Asia Pacific Spinal Devices and Biologics Consumption by Regions (2015-2020) (K Units)
Table 45. Latin America Spinal Devices and Biologics Consumption by Application (2015-2020) (K Units)
Table 46. Latin America Spinal Devices and Biologics Consumption by Countries (2015-2020) (K Units)
Table 47. Middle East and Africa Spinal Devices and Biologics Consumption by Application (2015-2020) (K Units)
Table 48. Middle East and Africa Spinal Devices and Biologics Consumption by Countries (2015-2020) (K Units)
Table 49. Global Spinal Devices and Biologics Production by Type (2015-2020) (K Units)
Table 50. Global Spinal Devices and Biologics Production Share by Type (2015-2020)
Table 51. Global Spinal Devices and Biologics Revenue by Type (2015-2020) (Million US$)
Table 52. Global Spinal Devices and Biologics Revenue Share by Type (2015-2020)
Table 53. Spinal Devices and Biologics Price by Type 2015-2020 (USD/Unit)
Table 54. Global Spinal Devices and Biologics Consumption by Application (2015-2020) (K Units)
Table 55. Global Spinal Devices and Biologics Consumption Share by Application (2015-2020)
Table 56. Nuvasive Corporation Information
Table 57. Nuvasive Description and Major Businesses
Table 58. Nuvasive Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 59. Nuvasive Product
Table 60. Nuvasive Recent Development
Table 61. Orthofix International Corporation Information
Table 62. Orthofix International Description and Major Businesses
Table 63. Orthofix International Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 64. Orthofix International Product
Table 65. Orthofix International Recent Development
Table 66. Exactech Corporation Information
Table 67. Exactech Description and Major Businesses
Table 68. Exactech Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 69. Exactech Product
Table 70. Exactech Recent Development
Table 71. Wright Medical Group Corporation Information
Table 72. Wright Medical Group Description and Major Businesses
Table 73. Wright Medical Group Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Wright Medical Group Product
Table 75. Wright Medical Group Recent Development
Table 76. Johnson & Johnson Corporation Information
Table 77. Johnson & Johnson Description and Major Businesses
Table 78. Johnson & Johnson Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Johnson & Johnson Product
Table 80. Johnson & Johnson Recent Development
Table 81. Zimmer Biomet Corporation Information
Table 82. Zimmer Biomet Description and Major Businesses
Table 83. Zimmer Biomet Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Zimmer Biomet Product
Table 85. Zimmer Biomet Recent Development
Table 86. Globus Medical Corporation Information
Table 87. Globus Medical Description and Major Businesses
Table 88. Globus Medical Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Globus Medical Product
Table 90. Globus Medical Recent Development
Table 91. K2M Corporation Information
Table 92. K2M Description and Major Businesses
Table 93. K2M Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. K2M Product
Table 95. K2M Recent Development
Table 96. Medtronic Corporation Information
Table 97. Medtronic Description and Major Businesses
Table 98. Medtronic Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Medtronic Product
Table 100. Medtronic Recent Development
Table 101. Alphatec Holdings Corporation Information
Table 102. Alphatec Holdings Description and Major Businesses
Table 103. Alphatec Holdings Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Alphatec Holdings Product
Table 105. Alphatec Holdings Recent Development
Table 106. RTI Surgical Corporation Information
Table 107. RTI Surgical Description and Major Businesses
Table 108. RTI Surgical Spinal Devices and Biologics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. RTI Surgical Product
Table 110. RTI Surgical Recent Development
Table 111. Global Spinal Devices and Biologics Revenue Forecast by Region (2021-2026) (Million US$)
Table 112. Global Spinal Devices and Biologics Production Forecast by Regions (2021-2026) (K Units)
Table 113. Global Spinal Devices and Biologics Production Forecast by Type (2021-2026) (K Units)
Table 114. Global Spinal Devices and Biologics Revenue Forecast by Type (2021-2026) (Million US$)
Table 115. North America Spinal Devices and Biologics Consumption Forecast by Regions (2021-2026) (K Units)
Table 116. Europe Spinal Devices and Biologics Consumption Forecast by Regions (2021-2026) (K Units)
Table 117. Asia Pacific Spinal Devices and Biologics Consumption Forecast by Regions (2021-2026) (K Units)
Table 118. Latin America Spinal Devices and Biologics Consumption Forecast by Regions (2021-2026) (K Units)
Table 119. Middle East and Africa Spinal Devices and Biologics Consumption Forecast by Regions (2021-2026) (K Units)
Table 120. Spinal Devices and Biologics Distributors List
Table 121. Spinal Devices and Biologics Customers List
Table 122. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 123. Key Challenges
Table 124. Market Risks
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Spinal Devices and Biologics Product Picture
Figure 2. Global Spinal Devices and Biologics Production Market Share by Type in 2020 & 2026
Figure 3. Spinal Fusion & Fixation Product Picture
Figure 4. Motion Preservation Product Picture
Figure 5. Non-Fusion Technologies Product Picture
Figure 6. Fracture Treatment Product Picture
Figure 7. Other Product Picture
Figure 8. Global Spinal Devices and Biologics Consumption Market Share by Application in 2020 & 2026
Figure 9. Hospitals
Figure 10. Ambulatory Surgical Centers
Figure 11. Clinics
Figure 12. Other
Figure 13. Spinal Devices and Biologics Report Years Considered
Figure 14. Global Spinal Devices and Biologics Revenue 2015-2026 (Million US$)
Figure 15. Global Spinal Devices and Biologics Production Capacity 2015-2026 (K Units)
Figure 16. Global Spinal Devices and Biologics Production 2015-2026 (K Units)
Figure 17. Global Spinal Devices and Biologics Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 18. Spinal Devices and Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Spinal Devices and Biologics Production Share by Manufacturers in 2015
Figure 20. The Top 10 and Top 5 Players Market Share by Spinal Devices and Biologics Revenue in 2019
Figure 21. Global Spinal Devices and Biologics Production Market Share by Region (2015-2020)
Figure 22. Spinal Devices and Biologics Production Growth Rate in North America (2015-2020) (K Units)
Figure 23. Spinal Devices and Biologics Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 24. Spinal Devices and Biologics Production Growth Rate in Europe (2015-2020) (K Units)
Figure 25. Spinal Devices and Biologics Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 26. Spinal Devices and Biologics Production Growth Rate in China (2015-2020) (K Units)
Figure 27. Spinal Devices and Biologics Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 28. Spinal Devices and Biologics Production Growth Rate in Japan (2015-2020) (K Units)
Figure 29. Spinal Devices and Biologics Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 30. Global Spinal Devices and Biologics Consumption Market Share by Regions 2015-2020
Figure 31. North America Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. North America Spinal Devices and Biologics Consumption Market Share by Application in 2019
Figure 33. North America Spinal Devices and Biologics Consumption Market Share by Countries in 2019
Figure 34. U.S. Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. Canada Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. Europe Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. Europe Spinal Devices and Biologics Consumption Market Share by Application in 2019
Figure 38. Europe Spinal Devices and Biologics Consumption Market Share by Countries in 2019
Figure 39. Germany Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. France Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. U.K. Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. Italy Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Russia Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Asia Pacific Spinal Devices and Biologics Consumption and Growth Rate (K Units)
Figure 45. Asia Pacific Spinal Devices and Biologics Consumption Market Share by Application in 2019
Figure 46. Asia Pacific Spinal Devices and Biologics Consumption Market Share by Regions in 2019
Figure 47. China Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Japan Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. South Korea Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. India Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Australia Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Thailand Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Malaysia Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Philippines Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Vietnam Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Latin America Spinal Devices and Biologics Consumption and Growth Rate (K Units)
Figure 59. Latin America Spinal Devices and Biologics Consumption Market Share by Application in 2019
Figure 60. Latin America Spinal Devices and Biologics Consumption Market Share by Countries in 2019
Figure 61. Mexico Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 62. Brazil Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Argentina Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Middle East and Africa Spinal Devices and Biologics Consumption and Growth Rate (K Units)
Figure 65. Middle East and Africa Spinal Devices and Biologics Consumption Market Share by Application in 2019
Figure 66. Middle East and Africa Spinal Devices and Biologics Consumption Market Share by Countries in 2019
Figure 67. Turkey Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 68. Saudi Arabia Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 69. U.A.E Spinal Devices and Biologics Consumption and Growth Rate (2015-2020) (K Units)
Figure 70. Global Spinal Devices and Biologics Production Market Share by Type (2015-2020)
Figure 71. Global Spinal Devices and Biologics Production Market Share by Type in 2019
Figure 72. Global Spinal Devices and Biologics Revenue Market Share by Type (2015-2020)
Figure 73. Global Spinal Devices and Biologics Revenue Market Share by Type in 2019
Figure 74. Global Spinal Devices and Biologics Production Market Share Forecast by Type (2021-2026)
Figure 75. Global Spinal Devices and Biologics Revenue Market Share Forecast by Type (2021-2026)
Figure 76. Global Spinal Devices and Biologics Market Share by Price Range (2015-2020)
Figure 77. Global Spinal Devices and Biologics Consumption Market Share by Application (2015-2020)
Figure 78. Global Spinal Devices and Biologics Value (Consumption) Market Share by Application (2015-2020)
Figure 79. Global Spinal Devices and Biologics Consumption Market Share Forecast by Application (2021-2026)
Figure 80. Global Spinal Devices and Biologics Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 81. Global Spinal Devices and Biologics Revenue Market Share Forecast by Regions ((2021-2026))
Figure 82. Global Spinal Devices and Biologics Production Forecast by Regions (2021-2026) (K Units)
Figure 83. North America Spinal Devices and Biologics Production Forecast (2021-2026) (K Units)
Figure 84. North America Spinal Devices and Biologics Revenue Forecast (2021-2026) (US$ Million)
Figure 85. Europe Spinal Devices and Biologics Production Forecast (2021-2026) (K Units)
Figure 86. Europe Spinal Devices and Biologics Revenue Forecast (2021-2026) (US$ Million)
Figure 87. China Spinal Devices and Biologics Production Forecast (2021-2026) (K Units)
Figure 88. China Spinal Devices and Biologics Revenue Forecast (2021-2026) (US$ Million)
Figure 89. Japan Spinal Devices and Biologics Production Forecast (2021-2026) (K Units)
Figure 90. Japan Spinal Devices and Biologics Revenue Forecast (2021-2026) (US$ Million)
Figure 91. Global Spinal Devices and Biologics Consumption Market Share Forecast by Region (2021-2026)
Figure 92. Spinal Devices and Biologics Value Chain
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Porter's Five Forces Analysis
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs